The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free of charge provider of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Table Kaiser and Company Family Foundation. All rights reserved.. Health and Agencies departments prepare for swine flu Governments and drug companies are struggling with efforts to prepare for a possible resurgence of swine flu in the fall in addition to questioning who have should receive swine flu vaccines because they ramp up creation. The Boston Globe reports on low stockpiles as disease trackers prepare for the fall to see how the swine strain evolves.We are also readying Zalviso for MAA filing in Europe, and getting ready to initiate a Stage 3 clinical system for ARX-04 in the second half of the year. Fourth Quarter and Full Year 2013 Financial Results Net gain for the fourth one fourth of 2013 was $17.8 million, or $0.41 per share, weighed against a net lack of $10.5 million, or $0.41 per share for the fourth quarter of 2012. During the fourth quarter of 2013, AcelRx received a $30.0 million upfront payment from Grunenthal GmbH associated with the Zalviso commercialization agreement in the Australia and EU, of which $27.4 million was named revenue in the quarter.4 million of revenue recognized from the Grunenthal collaboration, and excluding a $1.2 million one-time noncash charge linked to the Hercules personal debt renegotiation and $0.7 million noncash expense caused by the liability accounting related to warrants issued regarding the the PIPE financing completed in June 2012, the web reduction for the fourth quarter of 2013 was $7.7 million, or $0.18 per share.